刷新创新药出海纪录!百利天恒拿下ADC单笔最高里程碑付款

药财社
Dec 03

本文约2600字,阅读时长约8分钟12月1日,百利天恒公告披露,其全资子公司SystImmune已收到百时美施贵宝(BMS)支付的2.5亿美元里程碑付款(扣除银行手续费后以实际到账为准)。触发条件来自核心产品iza-bren(BL-B01D1,EGFR×HER3双抗ADC)在全球II/III期关键注册研究IZABRIGHT-Breast01中达成预设里程碑。加上2023年12月合作签署时支付的8...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10